Extrahepatic Manifestations of Hepatitis C Virus Infection

  1. Jose Luis Perez-Castrillon, MD; and
  2. Miguel Martin-Luguero, MD
  1. Hospital Rio Hortega, Valladolid, Spain

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Gumber and Chopra [1] wrote an excellent review of extrahepatic manifestations of HCV infection. However, the review does not mention the association between HCV infection and B-cell non-Hodgkin lymphoma.

    Ferri and colleagues [2] showed the presence of HCV infection in 17 patients (30%) of 50 unselected patients with B-cell non-Hodgkin lymphoma. Cryoglobulinemia was detected in 8% of these patients. This association is particularly significant compared with the prevalence of HCV infection in the healthy Italian population (1.3%). Pozzato and associates [3] showed a high prevalence of non-Hodgkin lymphoma in patients with cryoglobulinemia and HCV infection. The presence of viral genome in peripheral lymphocytes [4] suggests that the HCV genome is directly involved in the lymphoproliferative process that leads to lymphoma.

    Jose Luis Perez-Castrillon, MD

    Miguel Martin-Luguero, MD

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    References

    1. 1.
    2. 2.
    3. 3.
    4. 4.
    « Previous | Next Article »Table of Contents

    Navigate This Article